What is the CURB‑65 scoring system and how does it determine disposition and antibiotic therapy for patients with community‑acquired pneumonia?

CURB-65 Scoring System for Community-Acquired Pneumonia

CURB-65 is a simple 5-point clinical scoring system that assigns one point for each of the following criteria: Confusion, Urea >7 mmol/L (BUN >20 mg/dL), Respiratory rate ≥30/min, Blood pressure (systolic <90 mmHg or diastolic ≤60 mmHg), and age ≥65 years—with scores of 0-1 indicating outpatient treatment, score of 2 requiring short hospital stay or supervised outpatient care, and scores of 3-5 mandating hospitalization with ICU assessment. 1

How the Score Works

Calculate one point for each present criterion:

• Confusion (new disorientation to person, place, or time)
• Urea >7 mmol/L (or BUN >20 mg/dL in US units)
• Respiratory rate ≥30 breaths/minute
• Blood pressure: systolic <90 mmHg OR diastolic ≤60 mmHg
• 65 years of age or older

The total score ranges from 0 to 5 points. 1, 2

Disposition Based on Score

The mortality risk and recommended site of care directly correlate with the score 1:

• Score 0: 0.7% mortality → Outpatient treatment
• Score 1: 2.1% mortality → Outpatient treatment
• Score 2: 9.2% mortality → Short hospital stay or supervised outpatient care
• Score 3: 14.5% mortality → Hospital admission, assess for ICU
• Score 4: 40% mortality → Hospital admission, assess for ICU
• Score 5: 57% mortality → Hospital admission, assess for ICU

A simplified CRB-65 version (omitting the urea measurement) can be used when blood tests are not immediately available, particularly useful in remote or pre-hospital settings. 2, 3

Antibiotic Selection by Risk Category

Low-Risk Outpatients (CURB-65 0-1)

For healthy adults without comorbidities 4:

• Amoxicillin 1g three times daily (preferred), OR
• Doxycycline 100mg twice daily, OR
• Macrolide (azithromycin, clarithromycin) only if local pneumococcal macrolide resistance is <25%

Recent data supports amoxicillin as effective first-line therapy for low-risk CAP, with high discharge rates (86.95%) and low readmission rates (8.70%). 5

Moderate-Risk Outpatients with Comorbidities (CURB-65 0-2)

For patients with chronic heart, lung, liver, or renal disease; diabetes; alcoholism; malignancy; or asplenia 4:

Combination therapy:

• Amoxicillin/clavulanate (500/125mg three times daily OR 875/125mg twice daily) OR cephalosporin (cefpodoxime 200mg twice daily OR cefuroxime 500mg twice daily)
• PLUS macrolide OR doxycycline

OR Monotherapy:

• Respiratory fluoroquinolone (levofloxacin 750mg daily, moxifloxacin 400mg daily, or gemifloxacin 320mg daily)

Hospitalized Patients (CURB-65 2-5)

Most hospitalized patients receive combination β-lactam plus macrolide therapy. 6 The specific regimen should follow local hospital protocols, but typically includes:

• IV β-lactam (ceftriaxone, cefotaxime, or ampicillin-sulbactam)
• PLUS macrolide (azithromycin or clarithromycin)

Duration of therapy: 3-5 days minimum for non-severe CAP once clinical stability is achieved (afebrile, hemodynamically stable, improving respiratory symptoms). For severe CAP requiring ICU admission, continue antibiotics for ≥5 days. 7

Critical Limitations and Pitfalls

CURB-65 has significant limitations for ICU triage decisions. 1, 8 The score may:

• Underestimate severity in young patients without comorbidities who develop severe respiratory failure, since hypoxia alone doesn't score highly enough
• Underestimate risk in elderly patients with multiple comorbidities
• Miss patients requiring critical care interventions: In one study, 15.6% of patients with CURB-65 0-1 were admitted to ICU, and 6.4% received critical care interventions 8

For patients with CURB-65 ≥3 or any patient requiring mechanical ventilation or vasopressors, use the IDSA/ATS severe CAP criteria for ICU admission decisions rather than CURB-65 alone. 9 These major criteria include:

• Invasive mechanical ventilation requirement
• Septic shock requiring vasopressors

Clinical judgment must override the score when external factors are present, including 2:

• Important comorbidities not captured by the score (HIV, immunosuppression)
• Failure of prior outpatient antibiotic therapy
• Social factors (inability to obtain or reliably take medications, lack of support at home)
• Pregnancy
• Rapidly deteriorating clinical status

Do not withhold antibiotics based solely on positive viral testing in patients with imaging findings consistent with pneumonia, comorbidities, or those requiring admission—bacterial co-infection is common. 10, 7

C-reactive protein (CRP) levels can augment decision-making when uncertainty exists: CRP >100 mg/L strongly suggests bacterial pneumonia, while CRP <20 mg/L makes it less likely. However, CRP 20-100 mg/L has poor specificity. 3, 6 Additionally, failure of CRP to decline by >50% by day 4 predicts higher complication rates and mortality. 6